Konstantin H Dragnev

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Top Venues

Journal of cell science

Cancer prevention research (Philadelphia, Pa.)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Stephanie J Bouley, Andrew V Grassetti, Robert J Allaway, Matthew D Wood, Helen W Hou, India R Burdon Dasbach, William L Seibel, Jimmy Wu, Scott A Gerber, Konstantin H Dragnev, James A Walker, Yolanda Sanchez
Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of cell science 137 (15) (2024)
Stephanie J Bouley, Andrew V Grassetti, Robert J Allaway, Matthew D Wood, Helen W Hou, India R Burdon Dasbach, William L Seibel, Jimmy Wu, Scott A Gerber, Konstantin H Dragnev, James A Walker, Yolanda Sanchez
Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of cell science (2024)
Stephanie J Bouley, Andrew V Grassetti, Robert J Allaway, Matthew D Wood, Helen W Hou, India R Burdon Dasbach, William L Seibel, Jimmy Wu, Scott A Gerber, Konstantin H Dragnev, James A Walker, Yolanda Sanchez
Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of cell science 137 (15) (2024)
Stephanie J Bouley, Andrew V Grassetti, Robert J Allaway, Matthew D Wood, Helen W Hou, India R Burdon Dasbach, William L Seibel, Jimmy Wu, Scott A Gerber, Konstantin H Dragnev, James A Walker, Yolanda Sanchez
Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of cell science 137 (15) (2024)
Stephanie J Bouley, Andrew V Grassetti, Robert J Allaway, Matthew D Wood, Helen W Hou, India R Burdon Dasbach, William L Seibel, Jimmy Wu, Scott A Gerber, Konstantin H Dragnev, James A Walker, Yolanda Sanchez
Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss. Journal of cell science 137 (15) (2024)
Sai Yendamuri, Konstantin H Dragnev
Biomarker-Driven Personalized Immunoprevention: Toward More Efficient Clinical Trials? Cancer prevention research (Philadelphia, Pa.) (2024)
Konstantin H Dragnev, Ronald A Lubet, Mark Steven Miller, Shizuko Sei, Jennifer T Fox, Ming You
PRIMARY PREVENTION AND INTERCEPTION STUDIES IN RAS-MUTATED TUMOR MODELS EMPLOYING SMALL MOLECULES OR VACCINES. Cancer prevention research (Philadelphia, Pa.) (2023)
Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, James Moon, Philip C Mack, Gregory J Gerstner, Timothy F Burns, Asma Taj, Wallace L Akerley, Konstantin H Dragnev, Noel Laudi, Mary W Redman, Jhanelle E Gray, David R Gandara, Karen Kelly
Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC) (SWOG S1507, NCT-02642042). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)